Comparison of analytical platforms for cerebrospinal fluid measures of Aβ(1-42), total tau and p-tau(181) for identifying Alzheimer’s disease amyloid plaque pathology

Documenti analoghi

• Cerebrospinal fluid amyloid β(42), phosphorylated tau(181), and resting state functional connectivity
  di: Wang, Liang, et al.
  Pubblicazione: (2013)
• Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
  di: Fagan, Anne M, et al.
  Pubblicazione: (2009)
• Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
  di: Kaplow, June, et al.
  Pubblicazione: (2020)
• Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau(181), and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
  di: Kang, Ju-Hee, et al.
  Pubblicazione: (2013)
• Comparison of Cerebrospinal Fluid Levels of Tau and Aß(1-42) in Alzheimer’s disease and Frontotemporal Degeneration Using Two Analytical Platforms
  di: Irwin, David J., et al.
  Pubblicazione: (2012)